期刊文献+

吡格列酮对自发性高血压大鼠心脏成纤维细胞周期的影响 被引量:1

Effects of Pioglitazone on cell cycle of cardiac fibroblasts in spontaneous hypertesion rats
下载PDF
导出
摘要 目的研究盐酸吡格列酮对培养的自发性高血压大鼠(SHR)和血压正常大鼠(WKY)心脏成纤维细胞(CFs)细胞周期的影响,并进一步探讨其与NO-NOS系统的关系。方法采用胶原酶消化法培养SHR和WKY的CFs,流式细胞仪(FCM)分析技术检测细胞周期,硝酸还原酶法测定CFs培养上清NO浓度,分光光度法测定CFs培养上清NOS活性。结果0.1、1、5和10μmol/L的吡格列酮作用48h后,SHR、WKY CFs的G0/G1期细胞百分率较对照组显著增高(均P<0.01),S期细胞百分率、G2/M期细胞百分率和增殖指数则显著低于对照组(P<0.01,P<0.05),且随着作用浓度的增加,吡格列酮对细胞周期的影响逐渐增强。5μmol/L的吡格列酮干预48 h后,SHR和WKY的CFs培养上清NO浓度分别为(111.2±12.4)μmol/L和(221.7±35.3)μmol/L,与各自对照组(76.8±2.4)μmol/L、(112.1±8.9)μmol/L相比,差异非常显著(P<0.01);SHR和WKY大鼠CFs培养上清NOS活性分别为(208±18)μkat/L、(257±30)μkat/L,和各自对照组(148±10)μkat/L、(187±8)μkat/L相比,亦有非常显著性差异(P<0.01)。NO浓度和NOS活性呈显著正相关(r=0.964,P<0.01)。结论吡格列酮能够抑制SHR CFs的细胞周期增殖,其效应可能与上调NO-NOS系统活性有关。 AIM To evaluate the effects of insulin-sensitizer Pioglitazone on the cell cycle of cardiac fibroblasts (CFs) isolated from SHR and WKY rat and the activity of NO-NOS. METHODS Isolated and cultured CFs of SHR and WKY rats were used as experiment model. Cell cycle was determined by FCM. Nitrate enzyme reverting methods and spectrophotometer were also adopted to detect the content of NO and activity of NOS in CFs of SHR and WKY rats with or without Pioglitazone. RESULTS Based on the analysis of FCM cell cycle, it was shown that the percentage of cells on S and PI stages in CFs of SHR and Wistar was gradually declined as Pioglitazone concentration increased, while the percentage of cells on G0/G1 stages rose(P 〈 0.01 ). In SHR and Wistar rats, the NO concentration in supematant (111.2± 12.4) μmol/L, (221.7± 35.3 ) μmol/L, respectively treated by 5 μmol/L pioglitazone for 48 hours, was significantly higher than that of control group (76.8 ± 2.4) μmol/L, ( 112. 1± 8.9)μmol/L, respectively, P 〈 0. 01. NOS activity in supernatant of SHR and Wistar rats [ (208 ±18 ) μkat/L, (257±30) μkat/L, respectively ] treated by 5 μmol/L pioglitazone for 48 hours, was also significantly higher than that of control group (148 ±10) μkat/L, (187 ±8)μkat/L, respectively, P 〈0. 01. There was a significantly positive correlation between NO contents and NOS activity (r = 0. 964, P 〈 0. 01 ). CONCLUSION Insulin-sensitizer hydrochloride Pioglitazone inhabits the cell cycle proliferation of CFs of SHR in vitro, which may related with the up-regulation of NO-NOS system.
出处 《心脏杂志》 CAS 2008年第3期305-308,共4页 Chinese Heart Journal
关键词 细胞周期 吡格列酮 自发性高血压大鼠 心脏成纤维细胞 cell cycle pioglitazone spontaneous hypertesion rat cardiac fibroblasts
  • 相关文献

参考文献17

二级参考文献40

  • 1周庆峰,王洪新,王怡薇,单丹,符丽娟.吡格列酮对高糖高胰岛素诱导的心肌细胞肥大的影响[J].中国药理学通报,2004,20(7):818-821. 被引量:8
  • 2齐颖新,牛小麟,赵忠良.高血压对大鼠心肌PPAR-γ表达水平的影响及其意义[J].生物化学与生物物理进展,2004,31(10):941-946. 被引量:4
  • 3全国高血压,冠心病与糖尿病专题研讨会纪要[J].中华心血管病杂志,1993,21(5):260-265. 被引量:105
  • 4胡肇衡,路影,毛腾淑.非胰岛素依赖型糖尿病合并冠心病者的胰岛素抵抗[J].中华内科杂志,1997,36(3):173-176. 被引量:17
  • 5[1]Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology[J]. Hypertension, 1997,29: 691-699.
  • 6[2]Edwards JG, Tipton CM. Influences of exogenous insulin on arterial blood pressure measurements of the rat[J]. J Appl Physiol, 1989, 67:2335-2342.
  • 7[3]Anderson EA, Hoffman RP, Balon TW, et al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans[J]. J Clin Invest, 1991, 87:2246-2252.
  • 8[4]Ferrari P, Weidmann P, Shaw S, et al. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent[J]. Am J Med, 1991, 91:589-596.
  • 9[5]Walsh MF, Barazi M, Pete G, et al. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: Role of vascular nitric oxide[J]. Endocrinol, 1996, 137:1798-1803.
  • 10[6]Ren J, Sowers JR, Natavio M, et al. Influence of age on inotropic response to insulin and insulin-like growth factor I in spontaneously hypertensive rats: Role of nitric oxide[J]. Proc Soc Exp Biol Med, 1999,221:46-52.

共引文献16

同被引文献11

  • 1臧益民,樊荣.加强多学科协作,争取心血管病研究取得新进展[J].心脏杂志,2006,18(5):483-488. 被引量:24
  • 2Liu HR, Tao L, Gao E, et al. Rosiglitazone inhibits hypercholester- olaemia-induced myeloperoxidase upregulation--a novel mechanismfor the cardioprotective effects of PPAR agonists [ J ]. Cardiovasc Res, 2009, 81(2):344-352.
  • 3Tao L, Wang Y, Gao E, et al. Adiponectin: an indispensable mole- cule in rosiglitazone cardioprotection following myocardial infarction [J]. Circ Res, 2010, 106(2) :409 -417.
  • 4Makino N, Sugano M, Satoh S, et al. Peroxisome proliferator-acti- vated receptor-gamma ligands attenuate brain natriuretic peptide pro- duction and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia[ J]. Cell Biochem Biophys, 2006, 44( 1 ) :65 -71.
  • 5Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary pre- vention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trim In macroVascular Events) : a randomised controlled trial [ J ]. Lancet, 2005, 366(9493) :1279 - 1289.
  • 6Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocar- dial infarction and death from cardiovascular causes [ J ]. N Engl J Med, 2007, 356(24) :2457 -2471.
  • 7Babaev VR, Yancey PG, Ryzhov SV, et al. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25 ( 8 ) : 1647 - 1653.
  • 8Tao L, Liu HR, Gao E, et al. Antioxidative, antinitrative, and vas- culoprotective effects of a peroxisome proliferator-activated receptor- gamma agonist in hypercholesterolemia[ J]. Circulation, 2003, 108 (22) :2805 -2811.
  • 9黄洁,王海昌,马恒,高峰.老年大鼠主动脉对胰岛素敏感性的改变及其机制[J].心脏杂志,2007,19(4):409-412. 被引量:1
  • 10张英梅,李兰荪,陆松鹤,苏海霞,沈敏,张殿新,王海昌.PPARγC161-T基因多态性与冠脉粥样硬化的相关性[J].心脏杂志,2007,19(4):431-433. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部